However, features relating SVs across histologic subtypes, or genomic (BRAF-, (N)RAS-, and NF1-mutant and triple-wild-type [TWT]) subtypes of melanoma (which have been shown to have distinct secondary driver genes and pathways) (10), remain incompletely characterized. The gene discussed is BRAF; the disease is melanoma.